Platelet Function Testing and Genotyping for Tailoring Treatment in Complex PCI Patients
Dual antiplatelet therapy (DAPT), comprising aspirin and a P2Y12 receptor inhibitor, is considered the cornerstone of treatment in patients who have undergone percutaneous coronary intervention (PCI). Patients with complex PCI (C-PCI) constitute a special PCI subpopulation, characterized by increase...
Saved in:
| Main Authors: | Athanasios Moulias, Angeliki Papageorgiou, Dimitrios Alexopoulos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2021-08-01
|
| Series: | US Cardiology Review |
| Online Access: | https://www.uscjournal.com/articleindex/usc.2020.33 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prophylactic VA-ECMO During Complex High-Risk PCI
by: Chenliang Pan, MD, et al.
Published: (2025-09-01) -
Platelet phenotypes and practical aspects of platelet function testing in cardiology
by: Zh. D. Kobalava, et al.
Published: (2023-12-01) -
Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
by: Despoina-Rafailia Benetou, et al.
Published: (2021-10-01) -
Effects of intensive rosuvastatin on ventricular remodeling and cardiac function in elderly patients with STEMI undergoing PCI
by: Yiran Qin, et al.
Published: (2025-08-01) -
Social capital as a determinant of quality of life in greek cancer patients: a cross-sectional study
by: Athanasios Pitis, et al.
Published: (2025-08-01)